Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: when the remission state hides different types of residual disease activity
Sign Up to like & getrecommendations! Published in 2022 at "Gut"
DOI: 10.1136/gutjnl-2022-327321
Abstract: Objective Despite being in sustained and stable remission, patients with Crohn’s disease (CD) stopping anti-tumour necrosis factor α (TNFα) show a high rate of relapse (~50% within 2 years). Characterising non-invasively the biological profiles of… read more here.
Keywords: mid long; disease; clinical relapse; relapse ... See more keywords
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14061189
Abstract: This study investigated the kinetics in HBsAg and the HBsAg loss rate after entecavir or tenofovir disoproxil fumarate (TDF) cessation in patients with chronic hepatitis B (CHB) who achieved virological suppression after virological relapse without… read more here.
Keywords: kinetics hbsag; entecavir tenofovir; virological relapse; clinical relapse ... See more keywords
Identification of clinical and immunological factors associated with clinical relapse of pemphigus vulgaris in remission
Sign Up to like & getrecommendations! Published in 2019 at "Indian Journal of Dermatology, Venereology and Leprology"
DOI: 10.4103/ijdvl.ijdvl_89_19
Abstract: Background: Pemphigus vulgaris is a potentially fatal autoimmune epidermal blistering disease with a chronic and relapsing course. It is difficult to predict clinical relapse. Identification of clinical and immunological factors that are associated with early… read more here.
Keywords: pemphigus vulgaris; clinical relapse; remission; study ... See more keywords